نتایج جستجو برای: anti vegf

تعداد نتایج: 383792  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2010
Sung-Suk Chae Walid S Kamoun Christian T Farrar Nathaniel D Kirkpatrick Elisabeth Niemeyer Annemarie M A de Graaf A Gregory Sorensen Lance L Munn Rakesh K Jain Dai Fukumura

PURPOSE In brain tumors, cerebral edema is a significant source of morbidity and mortality. Recent studies have shown that inhibition of vascular endothelial growth factor (VEGF) signaling induces transient vascular normalization and reduces cerebral edema, resulting in a modest survival benefit in glioblastoma patients. During anti-VEGF treatment, circulating levels of angiopoietin (Ang)-2 rem...

حاجی قاسمی, فاطمه, میرشفیعی, عباس,

Background: Vascular endothelial growth factor (VEGF) has mitogenic effect for endothelial cells and is an important mediator of tumor expansion, metastasis and angiogenesis in vivo. Isosorbide dinitrate, as a nitric oxide donor, has been widely used in treatment of many cardiovascular diseases such as congestive heart failure and acute coronary syndromes. Furthermore this drug was found to hav...

Journal: :Biochemical Society transactions 2009
Yan Qiu Coralie Hoareau-Aveilla Sebastian Oltean Steven J Harper David O Bates

Anti-angiogenic VEGF (vascular endothelial growth factor) isoforms, generated from differential splicing of exon 8, are widely expressed in normal human tissues but down-regulated in cancers and other pathologies associated with abnormal angiogenesis (cancer, diabetic retinopathy, retinal vein occlusion, the Denys-Drash syndrome and pre-eclampsia). Administration of recombinant VEGF(165)b inhib...

Journal: :PloS one 2016
Da-Eun Hwang Jeong-Hyun Ryou Jong Rok Oh Jung Woo Han Tae Kwann Park Hak-Sung Kim

Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness among people over the age of 60. Vascular endothelial growth factor (VEGF) plays a major role in pathological angiogenesis in AMD. Herein, we present the development of an anti- human VEGF repebody, which is a small-sized protein binder consisting of leucine-rich repeat (LRR) modules. The anti-VEGF repebody...

Journal: :Circulation research 2001
R J Tomanek A Sandra W Zheng T Brock R J Bjercke J S Holifield

The roles of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF [FGF-2]) in early postnatal regulation of coronary angiogenesis were investigated by administering neutralizing antibodies to these growth factors between postnatal days 5 and 12. Immunohistochemistry and Western blotting both revealed decreases in VEGF protein in the hearts of rats treated with eith...

Journal: :Journal of glaucoma 2009
Joseph J Tseng Sushma K Vance Kara E Della Torre Luis S Mendonca Michael J Cooney James M Klancnik John A Sorenson K Bailey Freund

PURPOSE To describe a series of previously normotensive eyes experiencing sustained elevated intraocular pressure (IOP) associated with long-term intravitreal antivascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration (AMD). PATIENTS AND METHODS Clinical data were reviewed for 25 eyes of 23 patients with neovascular AMD who had increased IOP while r...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2007
Hans-Peter Gerber Xiumin Wu Lanlan Yu Christian Wiesmann Xiao Huan Liang Chingwei V Lee Germaine Fuh Christine Olsson Lisa Damico David Xie Y Gloria Meng Johnny Gutierrez Racquel Corpuz Bing Li Linda Hall Linda Rangell Ron Ferrando Henry Lowman Franklin Peale Napoleone Ferrara

VEGF-A is important in tumor angiogenesis, and a humanized anti-VEGF-A monoclonal antibody (bevacizumab) has been approved by the FDA as a treatment for metastatic colorectal and nonsquamous, non-small-cell lung cancer in combination with chemotherapy. However, contributions of both tumor- and stromal-cell derived VEGF-A to vascularization of human tumors grown in immunodeficient mice hindered ...

2017
Fatemeh Kazemi-Lomedasht Kamran Pooshang-Bagheri Mahdi Habibi-Anbouhi Ensiyeh Hajizadeh-Safar Delavar Shahbazzadeh Hasan Mirzahosseini Mahdi Behdani

OBJECTIVES Lung cancer is the main leading cause of cancer death worldwide. Angiogenesis is the main step in proliferation and spreading of tumor cells. Targeting vascular endothelial growth factor (VEGF) is an effective approach for inhibition of cancer angiogenesis. Nanobodies (NBs) are a novel class of antibodies derived from the camel. Unique characteristics of Nbs like their small size and...

2013
Steven A. Stacker Marc G. Achen

The vascular endothelial growth factor (VEGF) family of soluble protein growth factors consists of key mediators of angiogenesis and lymphangiogenesis in the context of tumor biology. The members of the family, VEGF-A (also known as VEGF), VEGF-B, VEGF-C, VEGF-D, and placenta growth factor (PlGF), play important roles in vascular biology in both normal physiology and pathology. The generation o...

2015
Dong Hyun Jo Sung Wook Park Chang Sik Cho Michael B. Powner Jin Hyoung Kim Marcus Fruttiger Jeong Hun Kim Marià Alemany

Anti-vascular endothelial growth factor (VEGF) agents are the mainstay treatment for various angiogenesis-related retinal diseases. Currently, bevacizumab, a recombinant humanized anti-VEGF antibody, is trailed in retinopathy of prematurity, a vasoproliferative retinal disorder in premature infants. However, the risks of systemic complications after intravitreal injection of anti-VEGF antibody ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید